This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1989 Mar;7(3):403-4.

doi: 10.1200/JCO.1989.7.3.403.

Prognostic factors related to response to chemotherapy in metastatic breast cancer

No authors listed

PMID: 2918336
DOI: 10.1200/JCO.1989.7.3.403

Comment

Prognostic factors related to response to chemotherapy in metastatic breast cancer

No authors listed. J Clin Oncol. 1989 Mar.

. 1989 Mar;7(3):403-4.

doi: 10.1200/JCO.1989.7.3.403.

PMID: 2918336
DOI: 10.1200/JCO.1989.7.3.403

No abstract available

PubMed Disclaimer

Comment on

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
Tannock IF, Boyd NF, DeBoer G, Erlichman C, Fine S, Larocque G, Mayers C, Perrault D, Sutherland H. Tannock IF, et al. J Clin Oncol. 1988 Sep;6(9):1377-87. doi: 10.1200/JCO.1988.6.9.1377. J Clin Oncol. 1988. PMID: 2458438 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information